Clinical trial
Phase II Study of Single Agent Lenvatinib
NCT03168074
Study timeline
Study start (actual)2017-03-28Date precision: day
Registry last updated2017-06-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
lenvatinibDRUG · verified · RxNorm: lenvatinib
Sponsors & collaborators
National University Hospital, Singaporelead sponsor
Eisai Co., Ltd.collaborator
Tan Tock Seng Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03168074 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.